BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 21418098)

  • 1. Illness perceptions and glycaemic control in diabetes: a systematic review with meta-analysis.
    Mc Sharry J; Moss-Morris R; Kendrick T
    Diabet Med; 2011 Nov; 28(11):1300-10. PubMed ID: 21418098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes.
    Farmer AJ; Perera R; Ward A; Heneghan C; Oke J; Barnett AH; Davidson MB; Guerci B; Coates V; Schwedes U; O'Malley S
    BMJ; 2012 Feb; 344():e486. PubMed ID: 22371867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of blood glucose and HbA(1c) goals on glycaemic control in children and adolescents with Type 1 diabetes.
    Boot M; Volkening LK; Butler DA; Laffel LM
    Diabet Med; 2013 Mar; 30(3):333-7. PubMed ID: 23190135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data.
    Pickup JC; Freeman SC; Sutton AJ
    BMJ; 2011 Jul; 343():d3805. PubMed ID: 21737469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recall of HbA1c and self-management behaviours, patient activation, perception of care and diabetes distress in Type 2 diabetes.
    Willaing I; Rogvi SA; Bøgelund M; Almdal T; Schiøtz M
    Diabet Med; 2013 Apr; 30(4):e139-42. PubMed ID: 23331258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of baseline HbA1c and efficacy of current glucose-lowering therapies: a meta-analysis of randomized clinical trials.
    DeFronzo RA; Stonehouse AH; Han J; Wintle ME
    Diabet Med; 2010 Mar; 27(3):309-17. PubMed ID: 20536494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of illness perception interventions in type 2 diabetes: Effects on glycaemic control and illness perceptions.
    Alyami M; Serlachius A; O'Donovan CE; van der Werf B; Broadbent E
    Diabet Med; 2021 Mar; 38(3):e14495. PubMed ID: 33306203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient factors and glycaemic control--associations and explanatory power.
    Rogvi S; Tapager I; Almdal TP; Schiøtz ML; Willaing I
    Diabet Med; 2012 Oct; 29(10):e382-9. PubMed ID: 22540962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HbA(1c) in adults without known diabetes from southern Europe. Impact of the new diagnostic criteria in clinical practice.
    Bernal-Lopez MR; Santamaría-Fernandez S; Lopez-Carmona D; Tinahones FJ; Mancera-Romero J; Peña-Jimenez D; Jansen-Chaparro S; Baca-Osorio AJ; Cuesta-Muñoz AL; Serrano-Rios M; Gomez-Huelgas R
    Diabet Med; 2011 Nov; 28(11):1319-22. PubMed ID: 21966956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between glycaemic control and mortality in patients with type 2 diabetes in general practice (ZODIAC-11).
    Landman GW; van Hateren KJ; Kleefstra N; Groenier KH; Gans RO; Bilo HJ
    Br J Gen Pract; 2010 Mar; 60(572):172-5. PubMed ID: 20202363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis.
    Umpierre D; Ribeiro PA; Kramer CK; Leitão CB; Zucatti AT; Azevedo MJ; Gross JL; Ribeiro JP; Schaan BD
    JAMA; 2011 May; 305(17):1790-9. PubMed ID: 21540423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between self-monitored blood glucose values and glycated haemoglobin in insulin-treated patients with Type 2 diabetes.
    Sarwat S; Ilag LL; Carey MA; Shrom DS; Heine RJ
    Diabet Med; 2010 May; 27(5):589-92. PubMed ID: 20536957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of the benefits of self-monitoring of blood glucose on glycemic control in type 2 diabetes patients: an update.
    Poolsup N; Suksomboon N; Rattanasookchit S
    Diabetes Technol Ther; 2009 Dec; 11(12):775-84. PubMed ID: 20001678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Dietary Glycaemic Index on Glycaemia in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Ojo O; Ojo OO; Adebowale F; Wang XH
    Nutrients; 2018 Mar; 10(3):. PubMed ID: 29562676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of glycaemia with perceived threat of illness in patients with type 2 diabetes.
    Voigt A; Madrid E; Pacheco-Huergo V; Rastello A; Castro D; Navarro-Brito I; Oyaneder MJ
    Prim Care Diabetes; 2015 Dec; 9(6):426-31. PubMed ID: 25862461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes Mellitus in German Primary Care: quality of glycaemic control and subpopulations not well controlled - results of the DETECT study.
    Huppertz E; Pieper L; Klotsche J; Stridde E; Pittrow D; Böhler S; Lehnert H
    Exp Clin Endocrinol Diabetes; 2009 Jan; 117(1):6-14. PubMed ID: 18465681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term impact of HbA1c on morbidity and all-cause mortality in people with type 2 diabetes: a Danish population-based observational study.
    Skriver MV; Støvring H; Kristensen JK; Charles M; Sandbæk A
    Diabetologia; 2012 Sep; 55(9):2361-70. PubMed ID: 22736395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment.
    Nauck MA; Haastert B; Trautner C; Müller UA; Nauck MA; Heinemann L;
    Diabetologia; 2014 May; 57(5):868-77. PubMed ID: 24445534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of structure, process, and policy on HbA(1c) levels in treatment of children and adolescents with type 1 diabetes.
    Hanberger L; Samuelsson U; Berterö C; Ludvigsson J
    Diabetes Res Clin Pract; 2012 Jun; 96(3):331-8. PubMed ID: 22326692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasting plasma glucose 6-12 weeks after starting insulin glargine predicts likelihood of treatment success: a pooled analysis.
    Karl D; Zhou R; Vlajnic A; Riddle M
    Diabet Med; 2012 Jul; 29(7):933-6. PubMed ID: 22413808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.